Figure 1 | Scientific Reports

Figure 1

From: PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection

Figure 1

Positive and negative expression patterns of three PD-L1 antibodies. A representative case that showed triple-positive features for all three antibodies (a–d) exhibited > 90% of the stromal tumor-infiltrating lymphocytes (TIL) infiltration as well as intratumoral TIL. Discordant case which was positive for 22C3 and SP263 antibodies but lacked SP142 expression (e–h) presented with less TIL infiltration than that shown by the triple-positive case.

Back to article page